• Xinyu Liu, Jiguo Yang, Lu Zhang, Runmin Li, Bingchen Li, Xin Ge, and Yuanxiang Liu.
• College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China.
• Medicine (Baltimore). 2021 Aug 13; 100 (32): e26865e26865.

BackgroundThe incidence of insomnia is very high and seriously affects the lives of its patients. Long-term insomnia can induce other diseases and even cause sudden death. Tian Meng oral liquid is a type of Chinese patent medicine that has been used in the clinical treatment of insomnia and has certain clinical effects. However, its wide application is limited by the lack of evidence-based medical evaluation.MethodsUsing retrieval strategies, randomized controlled trials on Tian Meng oral liquid for insomnia were obtained from China National Knowledge Infrastructure, WanFang, Chinese Scientific Journals Database PubMed, Embase, and Cochrane Library, regardless of publication date or language. Studies were screened based on inclusion and exclusion criteria, and the Cochrane risk bias assessment tool was used to evaluate the quality of the studies. The meta-analysis was performed using RevMan 5.3 and STATA 14.2 software. Ultimately, the evidentiary grade for the results will be evaluated.ResultsThis study aims to evaluate the efficacy and safety of Tian Meng oral liquid in the treatment of insomnia and to provide a more reasonable option for clinical medication.ConclusionOur findings will provide a strong basis for the effectiveness and safety of Tian Meng oral liquid in the treatment of insomnia.Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

14 keywords...

hide…